Chemical Burns in Emergency Medicine Medication

  • Author: Robert D Cox, MD, PhD; Chief Editor: Rick Kulkarni, MD   more...
 
Updated: Jun 28, 2010
 

Medication Summary

Medications have a limited role in the treatment of most chemical burns. Topical antibiotic therapy is usually recommended for dermal and ocular burns. Calcium or magnesium salts are used for hydrofluoric acid burns. Pain medications are important for subsequent burn care.

Steroid therapy is controversial for caustic ingestions but may be helpful for treating upper airway inflammation. No evidence indicates that steroid therapy decreases incidence of stricture formation. Steroids may predispose the patient to infection and may mask signs of perforation. There has been some use of aloe products on mild burns; however, currently, no definitive information on their use for chemical burns is available.[20, 18]

Nonsteroidal anti-inflammatory agents do provide some degree of pain relief for mild burns by inhibition of prostaglandin mediators. These have not been evaluated for chemical burns and should be avoided in all cases of GI burns from ingestions.

After decontamination is performed on patients with chemical burns affecting a significant portion of the body, administer standard IV fluid and narcotic therapy as used for thermal burns. For additional information, see the Burns, Thermal article.

Next

Antibiotics

Class Summary

Topical and ophthalmic antibiotics are routinely used for dermal and ocular burns, respectively. The injured tissues lose many of their protective mechanisms and are at increased risk of infection.

Silver sulfadiazine (Silvadene)

 

Used topically for dermal burns and useful in the prevention of infections from second- or third-degree burns. Has bactericidal activity against many gram-positive and gram-negative bacteria, including yeast.

Erythromycin ophthalmic (E-Mycin)

 

Use prophylactically to prevent infections following ocular burns. Ointment has a very low incidence of allergic reactions. Other possible agents include polymyxin B, bacitracin, and ciprofloxacin solutions.

Neomycin/polymyxin B/bacitracin topical (Neosporin Topical)

 

Used topically for dermal burns and useful in prevention of infections from second- or third-degree burns. Has bactericidal activity against many gram-positive and gram-negative bacteria, including yeast. Preferable for face and visible areas.

Previous
Next

Analgesics

Class Summary

Pain control is essential to quality patient care. Analgesics ensure patient comfort and have sedating properties, which are beneficial for patients who have sustained injuries to the eye.

Morphine is recommended in the ED. For outpatient treatment, combinations of hydrocodone or oxycodone and acetaminophen are usually sufficient. Codeine is not recommended.

Nonsteroidal anti-inflammatory drugs (NSAIDs) are most commonly used for the relief of mild to moderate pain. Although effects of NSAIDs in the treatment of pain tend to be patient specific, ibuprofen is usually the DOC for initial therapy. Other options include flurbiprofen, ketoprofen, and naproxen.

Morphine sulfate (Duramorph, Astramorph, MS Contin)

 

DOC for narcotic analgesia because of reliable and predictable effects, safety profile, and ease of reversibility with naloxone.

Morphine sulfate administered IV may be dosed in a number of ways and is commonly titrated until the desired effect is obtained.

During the ED treatment of the acute burn, use IV (preferred) or IM for moderate or severe pain.

Acetaminophen with oxycodone (Tylox, Percocet)

 

Drug combination indicated for the relief of moderate to severe pain. DOC for aspirin-hypersensitive patients.

Formulations of oxycodone/acetaminophen are available as follows:

Tylox-5/500

Percocet-5/325

Percocet-7.5/500

Percocet-10/650

Acetaminophen with hydrocodone (Vicodin, Lorcet, Lortab, Norco)

 

Drug combination for outpatient use and indicated for the relief of moderate-to-severe pain.

Formulations of hydrocodone/acetaminophen are available as follows: Vicodin-5/500, ES-7.5/750, HP-10/600 Lorcet-10/650, Plus-7.5/650 Lortab-2.5/500, 5/500, 7.5/500, 10/500 Norco-10/325.

Typical elixirs contain 2.5 mg hydrocodone and 167 mg/mL acetaminophen.

Ibuprofen (Ibuprin, Advil, Motrin)

 

Usually the DOC for the treatment of mild to moderate pain, if no contraindications exist.

Inhibits inflammatory reactions and pain by decreasing activity of the enzyme cyclooxygenase, resulting in the inhibition of prostaglandin synthesis.

Useful for outpatient oral use where nonsedating drugs are preferred. Also has the advantage of an anti-inflammatory effect.

Ketoprofen (Oruvail, Orudis, Actron)

 

Used for the relief of mild to moderate pain and inflammation.

Initially administer small dosages to patients with a small body size, the elderly, and those with renal or liver disease.

When administering this medication, doses higher than 75 mg do not increase therapeutic effects. Administer high doses with caution, and closely observe patient for response.

Naproxen (Anaprox, Naprelan, Naprosyn)

 

Used for relief of mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing activity of enzyme cyclooxygenase, resulting in a decrease of prostaglandin synthesis.

Previous
Next

Decontaminants

Class Summary

These agents can help remove offending substances from the skin and minimize their caustic effects.

Polyethylene glycol

 

Used as an aid in removing phenol or cresols. Desired agent is PEG 400 mixed 50:50 in water. Most hospitals are not likely to have this product. If not available, use bowel-cleansing products containing PEG.

Previous
Proceed to Follow-up
 
 
Contributor Information and Disclosures
Author

Robert D Cox, MD, PhD  Professor, Department of Emergency Medicine, Associate Professor, Department of Pharmacology and Toxicology, University of Mississippi Medical Center; Medical Director, Mississippi Regional Poison Control Center

Robert D Cox, MD, PhD is a member of the following medical societies: American College of Emergency Physicians and American College of Medical Toxicology

Disclosure: Nothing to disclose.

Specialty Editor Board

Jerry Balentine, DO  Professor of Emergency Medicine, New York College of Osteopathic Medicine; Executive Vice President, Chief Medical Officer, Attending Physician in Department of Emergency Medicine, St Barnabas Hospital

Jerry Balentine, DO is a member of the following medical societies: American College of Emergency Physicians, American College of Osteopathic Emergency Physicians, American College of Physician Executives, American Osteopathic Association, and New York Academy of Medicine

Disclosure: Nothing to disclose.

John T VanDeVoort, PharmD  Regional Director of Pharmacy, Sacred Heart and St Joseph's Hospitals

John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists

Disclosure: Nothing to disclose.

Jon Mark Hirshon, MD, MPH  Associate Professor, Department of Emergency Medicine, University of Maryland School of Medicine

Jon Mark Hirshon, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Public Health Association, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD  Attending Physician, Department of Emergency Medicine, Cambridge Health Alliance, Division of Emergency Medicine, Harvard Medical School

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

References
  1. Taira BR, Singer AJ, Thode HC, Lee C. Burns in the Emergency Department: A National Perspective. J Emerg Med. Jul 2010;39(1):1-5.

  2. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Heard SE. 2007 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report. Clin Toxicol (Phila). Dec 2008;46(10):927-1057. [Medline].

  3. Barillo DJ, Cancio LC, Goodwin CW. Treatment of white phosphorus and other chemical burn injuries at one burn center over a 51-year period. Burns. Aug 2004;30(5):448-52. [Medline].

  4. Mannan A, Ghani S, Clarke A, Butler PE. Cases of chemical assault worldwide: a literature review. Burns. Mar 2007;33(2):149-54. [Medline].

  5. Maguina P, Shah-Khan M, An G, Hanumadass M. Chemical scalp burns after hair highlights. J Burn Care Res. Mar-Apr 2007;28(2):361-3. [Medline].

  6. Scarlett A, Gee P. Corneal abrasion and alkali burn secondary to automobile air bag inflation. Emerg Med J. Oct 2007;24(10):733-4. [Medline].

  7. Ramasamy K, Gumaste VV. Corrosive ingestion in adults. J Clin Gastroenterol. Aug 2003;37(2):119-24. [Medline].

  8. Gorman RL, Khin-Maung-Gyi MT, Klein-Schwartz W, et al. Initial symptoms as predictors of esophageal injury in alkaline corrosive ingestions. Am J Emerg Med. May 1992;10(3):189-94. [Medline].

  9. Leonard LG, Scheulen JJ, Munster AM. Chemical burns: effect of prompt first aid. J Trauma. May 1982;22(5):420-3. [Medline].

  10. Spector J, Fernandez WG. Chemical, thermal, and biological ocular exposures. Emerg Med Clin North Am. Feb 2008;26(1):125-36, vii. [Medline].

  11. Mozingo DW, Smith AA, McManus WF, et al. Chemical burns. J Trauma. May 1988;28(5):642-7. [Medline].

  12. Yano K, Hata Y, Matsuka K. Experimental study on alkaline skin injuries--periodic changes in subcutaneous tissue pH and the effects exerted by washing. Burns. Aug 1993;19(4):320-3. [Medline].

  13. Yano K, Hosokawa K, Kakibuchi M, et al. Effects of washing acid injuries to the skin with water: an experimental study using rats. Burns. Nov 1995;21(7):500-2. [Medline].

  14. Lin TM, Lee SS, Lai CS, Lin SD. Phenol burn. Burns. Jun 2006;32(4):517-21. [Medline].

  15. Bertolini JC. Hydrofluoric acid: a review of toxicity. J Emerg Med. Mar-Apr 1992;10(2):163-8. [Medline].

  16. Cox RD, Osgood KA. Evaluation of intravenous magnesium sulfate for the treatment of hydrofluoric acid burns. J Toxicol Clin Toxicol. 1994;32(2):123-36. [Medline].

  17. Friedman EM, Lovejoy FH. The emergency management of caustic ingestions. Emerg Med Clin North Am. Feb 1984;2(1):77-86. [Medline].

  18. Salzman M, O'Malley RN. Updates on the evaluation and management of caustic exposures. Emerg Med Clin North Am. May 2007;25(2):459-76; abstract x. [Medline].

  19. Howell JM. Alkaline ingestions. Ann Emerg Med. Jul 1986;15(7):820-5. [Medline].

  20. Fulton JA, Hoffman RS. Steroids in second degree caustic burns of the esophagus: a systematic pooled analysis of fifty years of human data: 1956-2006. Clin Toxicol (Phila). May 2007;45(4):402-8. [Medline].

Previous
Next
 
Caustic oral burns.
Caustic burns of tongue.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.